The identification of rare genomic alterations in patients with colorectal cancer gives oncologists the opportunity to treat patients who otherwise might not have many options. When Mia Balko, 48, ...
The Alliance for Clinical Trials in Oncology (Alliance) today announced that the U.S. Food and Drug Administration has accepted for review Genentech's supplemental Biologic License Application for ...
People battling advanced colon cancers might have a new treatment option that could extend their survival, a new trial finds. The findings were present the at the annual meeting of the American ...
Neoadjuvant therapy for patients with metastatic colon cancer with single-organ liver or lung lesions was associated with improved overall survival in comparison with adjuvant therapy, according to ...
Personalizing Colon Cancer Adjuvant Therapy: Selecting Optimal Treatments for Individual Patients The following represents disclosure information provided by authors of this manuscript. All ...
A multidisciplinary team made up of doctors and scientists from the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and the Institute for Research in Biomedicine (IRB Barcelona) ...
Better out than in, they say? At least that seems to be the general consensus amongst the who's who of the wellness community—where colonics seem to be all the rage. If you're not familiar with the ...
Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway Are Associated With Clinical Outcomes in Esophageal Cancer Patients Treated With Chemoradiotherapy A significant overall survival (OS) benefit of ...
Based on: Chronic Intestinal Toxemia and Its Treatment: With special reference to colonic therapy. James W. Wiltsie. 268 pp. Baltimore: William Wood & Co., 1938. $3.00. Select the format you want to ...
Crohn’s disease can affect any part of the gastrointestinal tract; however, current European and national guidelines worldwide do not differentiate between small-intestinal and colonic Crohn’s disease ...
Chronic kidney disease (CKD) is a major public health burden around the world. The gut microbiome may contribute to CKD progression and serve as a promising therapeutic target. Colonic dialysis has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results